THE RISK OF CYTOMEGALOVIRUS-INFECTION IN SOLID ORGAN AND BONE-MARROW TRANSPLANT RECIPIENTS - TRANSFUSION OF BLOOD PRODUCTS

被引:47
作者
HILLYER, CD
SNYDMAN, DR
BERKMAN, EM
机构
[1] TUFTS UNIV,NEW ENGLAND MED CTR HOSP,SCH MED,DEPT MED,DIV HEMATOL ONCOL,BOSTON,MA 02111
[2] TUFTS UNIV,NEW ENGLAND MED CTR HOSP,SCH MED,DEPT PATHOL,BOSTON,MA 02111
[3] TUFTS UNIV,NEW ENGLAND MED CTR HOSP,SCH MED,DEPT CLIN MICROBIOL,BOSTON,MA 02111
[4] TUFTS UNIV,NEW ENGLAND MED CTR HOSP,SCH MED,DIV GEOG MED INFECT DIS,BOSTON,MA 02111
关键词
D O I
10.1046/j.1537-2995.1990.30790385528.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:659 / 666
页数:8
相关论文
共 88 条
  • [1] Adler S P, 1988, Transfus Med Rev, V2, P235, DOI 10.1016/S0887-7963(88)70051-6
  • [2] CYTOMEGALOVIRUS INFECTIONS IN NEONATES ACQUIRED BY BLOOD-TRANSFUSIONS
    ADLER, SP
    CHANDRIKA, T
    LAWRENCE, L
    BAGGETT, J
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1983, 2 (02) : 114 - 118
  • [3] ADLER SP, 1983, REV INFECT DIS, V5, P977
  • [4] DETECTION OF CYTOMEGALO-VIRUS ANTIBODY WITH LATEX AGGLUTINATION
    ADLER, SP
    MCVOY, M
    BIRO, VG
    BRITT, WJ
    HIDER, P
    MARSHALL, D
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (01) : 68 - 70
  • [5] ARMSTRONG JA, 1976, YALE J BIOL MED, V49, P83
  • [6] COMPARISON OF A LATEX AGGLUTINATION-TEST WITH 5 OTHER METHODS FOR DETERMINING THE PRESENCE OF ANTIBODY AGAINST CYTOMEGALO-VIRUS
    BECKWITH, DG
    HALSTEAD, DC
    ALPAUGH, K
    SCHWEDER, A
    BLOUNTFRONEFIELD, DA
    TOTH, K
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 21 (03) : 328 - 331
  • [7] BETTS RF, 1976, J CLIN MICROBIOL, V4, P151
  • [8] Bowden R.A., 1989, TRANSFUSION S, V29, P57
  • [9] CYTOMEGALOVIRUS IMMUNE GLOBULIN AND SERONEGATIVE BLOOD PRODUCTS TO PREVENT PRIMARY CYTOMEGALOVIRUS-INFECTION AFTER MARROW TRANSPLANTATION
    BOWDEN, RA
    SAYERS, M
    FLOURNOY, N
    NEWTON, B
    BANAJI, M
    THOMAS, ED
    MEYERS, JD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (16) : 1006 - 1010
  • [10] CYTOMEGALOVIRUS-SERONEGATIVE BLOOD COMPONENTS FOR THE PREVENTION OF PRIMARY CYTOMEGALOVIRUS-INFECTION AFTER MARROW TRANSPLANTATION - CONSIDERATIONS FOR BLOOD-BANKS
    BOWDEN, RA
    SAYERS, M
    GLEAVES, CA
    BANAJI, M
    NEWTON, B
    MEYERS, JD
    [J]. TRANSFUSION, 1987, 27 (06) : 478 - 481